Optimizing an mHealth Intervention to Improve Uptake and Adherence to HIV Pre-exposure Prophylaxis in Young Transgender Women: Protocol for a Multi-Phase Trial

Karen Kolmodin MacDonell, Bo Wang, Nittaya Phanuphak, Rena Janamnuaysook, Peevara Srimanus, Chokechai Rongkavilit, Sylvie Naar, Karen Kolmodin MacDonell, Bo Wang, Nittaya Phanuphak, Rena Janamnuaysook, Peevara Srimanus, Chokechai Rongkavilit, Sylvie Naar

Abstract

Background: Vulnerable adolescents and emerging adults (aged 18-29 years), particularly young transgender women, are among the fastest-growing HIV positive populations worldwide. Thailand has the highest adult HIV seroprevalence in Asia, with a rate of infection among this population of 18%. Widespread technology offers opportunities for innovative mobile health (mHealth) interventions. Pre-exposure prophylaxis (PrEP) is an efficacious HIV prevention strategy recommended for at-risk individuals. PrEP is highly effective when taken as prescribed, but uptake and adherence have been low, with high discontinuation rates among youth.

Objective: We propose to develop and pilot a multi-component, technology-based intervention to promote PrEP usage. We will adapt an existing 2-session, technology-delivered, motivational interviewing-based intervention to focus on PrEP use in transgender women in Thailand. We call this the Motivational Enhancement System for PrEP Uptake and Adherence (MES-PrEP). We will also refine and enhance YaCool, a mobile app with integrated text messaging developed and used clinically by our Thai team. The new version of the app is called Enhanced YaCool, and it enables self-management of gender and sexual health (including PrEP). Our primary aim is to develop and assess the preliminary efficacy of this mHealth intervention.

Methods: We will utilize a multiphase optimization strategy (MOST) to identify the most effective intervention component or combination of components to improve PrEP usage in Thai transgender women. The study includes two phases: phase I (R21) includes qualitative interviews with key stakeholders to explore barriers and facilitators of PrEP usage through thematic analysis to inform intervention adaptation. Following this, we will adapt and beta-test MES-PrEP and Enhanced YaCool for functionality and feasibility using a community advisory board of HIV-negative Thai transgender women. In phase II (R33), we will conduct a MOST design-based trial to evaluate the feasibility, acceptability, and preliminary efficacy of MES-PrEP and Enhanced YaCool. Eighty HIV-negative participants who are currently taking PrEP and 80 participants who are not will be randomized to four conditions: (1) standard PrEP counseling (the control condition); (2) MES-PrEP and standard PrEP counseling; (3) Enhanced YaCool and standard PrEP counseling; and (4) MES-PrEP, Enhanced YaCool, and standard PrEP counseling. Feasibility and acceptability of the intervention will be assessed through usage patterns and the System Usability Scale. Preliminary impact will be assessed by evaluating the proportion of participants who initiate PrEP and their level of adherence to PrEP. Assessments will be at baseline and 1, 3, 6, 9, and 12 months postintervention. Biomarkers of adherence to PrEP, HIV, and other sexually transmitted infections will be collected.

Results: Upon project completion, we will have an optimized mHealth intervention to support the use of PrEP by transgender women that will be ready for testing in a larger efficacy trial.

Conclusions: Even though transgender women in Thailand face increasing risks of HIV, few interventions have targeted them. Effective developmentally and culturally tailored interventions are needed to prevent HIV transmission in this high-risk population.

Trial registration: ClinicalTrials.gov NCT05262426; https://ichgcp.net/clinical-trials-registry/NCT05262426.

International registered report identifier (irrid): PRR1-10.2196/37659.

Keywords: HIV prevention; PrEP; Thailand; mHealth; mobile phone; motivational interviewing; transgender women.

Conflict of interest statement

Conflicts of Interest: None declared.

©Karen Kolmodin MacDonell, Bo Wang, Nittaya Phanuphak, Rena Janamnuaysook, Peevara Srimanus, Chokechai Rongkavilit, Sylvie Naar. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 19.05.2022.

Figures

Figure 1
Figure 1
Integrated application of the information-motivation-behavioral skills model and the socioecological model for uptake and adherence. PrEP: pre-exposure prophylaxis.

References

    1. Baral SD, Poteat T, Strömdahl S, Wirtz AL, Guadamuz TE, Beyrer C. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis. 2013 Mar;13(3):214–222. doi: 10.1016/s1473-3099(12)70315-8.
    1. Poteat T, Reisner SL, Radix A. HIV epidemics among transgender women. Curr Opin HIV AIDS. 2014;9(2):168–173. doi: 10.1097/coh.0000000000000030.
    1. Wilson EC, Garofalo R, Harris RD, Herrick A, Martinez M, Martinez J, Belzer M, Transgender Advisory Committeethe Adolescent Medicine Trials Network for HIV/AIDS Interventions Transgender female youth and sex work: HIV risk and a comparison of life factors related to engagement in sex work. AIDS Behav. 2009 Oct;13(5):902–13. doi: 10.1007/s10461-008-9508-8.
    1. Clark H, Babu AS, Wiewel EW, Opoku J, Crepaz N. Diagnosed HIV Infection in Transgender Adults and Adolescents: Results from the National HIV Surveillance System, 2009-2014. AIDS Behav. 2017 Sep;21(9):2774–2783. doi: 10.1007/s10461-016-1656-7. 10.1007/s10461-016-1656-7
    1. Schulden JD, Song B, Barros A, Mares-DelGrasso A, Martin CW, Ramirez R, Smith LC, Wheeler DP, Oster AM, Sullivan PS, Heffelfinger JD. Rapid HIV Testing in Transgender Communities by Community-Based Organizations in Three Cities. Public Health Rep. 2008 Nov 01;123(3_suppl):101–114. doi: 10.1177/00333549081230s313.
    1. Arnett JJ. Emerging adulthood: A theory of development from the late teens through the twenties. Am Psychol. 2000;55(5):469–480. doi: 10.1037/0003-066x.55.5.469.
    1. Arnett J. Emerging Adulthood. New York, NY: Oxford University Press; 2004. The Winding Road from the Late Teens through the Twenties.
    1. Country factsheets: Thailand. UNAIDS. 2017. [2020-08-15]. .
    1. The Asian Epidemic Model (AEM) Projections for HIV/AIDS in Thailand: 2005-2025 | HIV/AIDS Data Hub for the Asia-Pacific Region. HIV AIDS Asia Pacific Research Statistical Data Information Resources AIDS Data Hub. [2020-11-13]. .
    1. Reisner SL, Poteat T, Keatley J, Cabral M, Mothopeng T, Dunham E, Holland CE, Max R, Baral SD. Global health burden and needs of transgender populations: a review. The Lancet. 2016 Jul;388(10042):412–436. doi: 10.1016/s0140-6736(16)00684-x.
    1. Nuttbrock L, Bockting W, Rosenblum A, Hwahng S, Mason M, Macri M, Becker J. Gender Abuse, Depressive Symptoms, and Substance Use Among Transgender Women: A 3-Year Prospective Study. Am J Public Health. 2014 Nov;104(11):2199–2206. doi: 10.2105/ajph.2014.302106.
    1. Hotton AL, Garofalo R, Kuhns LM, Johnson AK. Substance Use as a Mediator of the Relationship Between Life Stress and Sexual Risk Among Young Transgender Women. AIDS Education and Prevention. 2013 Feb;25(1):62–71. doi: 10.1521/aeap.2013.25.1.62.
    1. Nemoto T, Operario D, Keatley J, Han L, Soma T. HIV risk behaviors among male-to-female transgender persons of color in San Francisco. Am J Public Health. 2004 Jul;94(7):1193–9. doi: 10.2105/ajph.94.7.1193.94/7/1193
    1. White Hughto JM, Reisner SL, Pachankis JE. Transgender stigma and health: A critical review of stigma determinants, mechanisms, and interventions. Soc Sci Med. 2015 Dec;147:222–31. doi: 10.1016/j.socscimed.2015.11.010. S0277-9536(15)30218-5
    1. Operario D, Soma T, Underhill K. Sex work and HIV status among transgender women: systematic review and meta-analysis. J Acquir Immune Defic Syndr. 2008 May 01;48(1):97–103. doi: 10.1097/QAI.0b013e31816e3971.
    1. Nemoto T, Operario D, Keatley J. Health and Social Services for Male-to-Female Transgender Persons of Color in San Francisco. Int J Transgenderism. 2005 Oct 11;8(2-3):5–19. doi: 10.1300/j485v08n02_02.
    1. 90-90-90: an ambitious treatment target to help end the AIDS epidemic. UNAIDS. 2014. [2022-03-01]. .
    1. Krishna S, Boren SA, Balas EA. Healthcare via cell phones: a systematic review. Telemed J E Health. 2009 Apr;15(3):231–40. doi: 10.1089/tmj.2008.0099.
    1. Mobile youth around the world. Nielsen. 2010. [2022-03-01]. .
    1. Clifford GD, Clifton D. Wireless technology in disease management and medicine. Annu Rev Med. 2012;63:479–92. doi: 10.1146/annurev-med-051210-114650.
    1. Grant Robert M, Lama Javier R, Anderson Peter L, McMahan Vanessa, Liu Albert Y, Vargas Lorena, Goicochea Pedro, Casapía Martín, Guanira-Carranza Juan Vicente, Ramirez-Cardich Maria E, Montoya-Herrera Orlando, Fernández Telmo, Veloso Valdilea G, Buchbinder Susan P, Chariyalertsak Suwat, Schechter Mauro, Bekker Linda-Gail, Mayer Kenneth H, Kallás Esper Georges, Amico K Rivet, Mulligan Kathleen, Bushman Lane R, Hance Robert J, Ganoza Carmela, Defechereux Patricia, Postle Brian, Wang Furong, McConnell J Jeff, Zheng Jia-Hua, Lee Jeanny, Rooney James F, Jaffe Howard S, Martinez Ana I, Burns David N, Glidden David V, iPrEx Study Team Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010 Dec 30;363(27):2587–99. doi: 10.1056/NEJMoa1011205.
    1. Poteat Tonia, Wirtz Andrea, Malik Mannat, Cooney Erin, Cannon Christopher, Hardy W David, Arrington-Sanders Renata, Lujan Maren, Yamanis Thespina. A Gap Between Willingness and Uptake: Findings From Mixed Methods Research on HIV Prevention Among Black and Latina Transgender Women. J Acquir Immune Defic Syndr. 2019 Oct 01;82(2):131–140. doi: 10.1097/QAI.0000000000002112.
    1. Draper BL, Oo ZM, Thein ZW, Aung PP, Veronese V, Ryan C, Thant M, Hughes C, Stoové M. Willingness to use HIV pre-exposure prophylaxis among gay men, other men who have sex with men and transgender women in Myanmar. J Int AIDS Soc. 2017 Jul 26;20(1):21885. doi: 10.7448/ias.20.1.21885.
    1. Deutsch MB, Glidden DV, Sevelius J, Keatley J, McMahan V, Guanira J, Kallas EG, Chariyalertsak S, Grant RM. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. The Lancet HIV. 2015 Dec;2(12):e512–e519. doi: 10.1016/s2352-3018(15)00206-4.
    1. Escudero DJ, Kerr T, Operario D, Socías Maria E, Sued O, Marshall BD. Inclusion of trans women in pre-exposure prophylaxis trials: a review. AIDS Care. 2015;27(5):637–41. doi: 10.1080/09540121.2014.986051.
    1. Ramautarsing RA, Meksena R, Sungsing T, Chinbunchorn T, Sangprasert T, Fungfoosri O, Meekrua D, Sumalu S, Pasansai T, Bunainso W, Wongsri T, Mainoy N, Colby D, Avery M, Mills S, Vannakit R, Phanuphak P, Phanuphak N. Evaluation of a pre-exposure prophylaxis programme for men who have sex with men and transgender women in Thailand: learning through the HIV prevention cascade lens. J Int AIDS Soc. 2020 Jun;23 Suppl 3:e25540. doi: 10.1002/jia2.25540.
    1. Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDS. 2013 Apr;27(4):248–54. doi: 10.1089/apc.2012.0419.
    1. Wood S, Gross R, Shea JA, Bauermeister JA, Franklin J, Petsis D, Swyryn M, Lalley-Chareczko L, Koenig HC, Dowshen N. Barriers and Facilitators of PrEP Adherence for Young Men and Transgender Women of Color. AIDS Behav. 2019 Oct;23(10):2719–2729. doi: 10.1007/s10461-019-02502-y. 10.1007/s10461-019-02502-y
    1. Rael CT, Martinez M, Giguere R, Bockting W, MacCrate C, Mellman W, Valente P, Greene GJ, Sherman S, Footer KHA, D'Aquila Richard T, Carballo-Diéguez Alex. Barriers and Facilitators to Oral PrEP Use Among Transgender Women in New York City. AIDS Behav. 2018 Nov;22(11):3627–3636. doi: 10.1007/s10461-018-2102-9. 10.1007/s10461-018-2102-9
    1. Naar-King S, Parsons JT, Johnson AM. Motivational interviewing targeting risk reduction for people with HIV: a systematic review. Curr HIV/AIDS Rep. 2012 Dec;9(4):335–43. doi: 10.1007/s11904-012-0132-x.
    1. Dillard PK, Zuniga JA, Holstad MM. An integrative review of the efficacy of motivational interviewing in HIV management. Patient Educ Couns. 2017 Apr;100(4):636–646. doi: 10.1016/j.pec.2016.10.029.S0738-3991(16)30498-0
    1. Lee M, Lee H, Kim Y, Kim J, Cho M, Jang J, Jang H. Mobile App-Based Health Promotion Programs: A Systematic Review of the Literature. Int J Environ Res Public Health. 2018 Dec 13;15(12):2383. doi: 10.3390/ijerph15122838. ijerph15122838
    1. Smith C, Gold J, Ngo T, Sumpter C, Free C. Mobile phone-based interventions for improving contraception use. Cochrane Database Syst Rev. 2015 Jun 26;(6):CD011159. doi: 10.1002/14651858.CD011159.pub2.
    1. Saberi P, Siedle-Khan R, Sheon N, Lightfoot M. The Use of Mobile Health Applications Among Youth and Young Adults Living with HIV: Focus Group Findings. AIDS Patient Care STDS. 2016 Jun;30(6):254–60. doi: 10.1089/apc.2016.0044.
    1. Muessig KE, Pike EC, Fowler B, LeGrand S, Parsons JT, Bull SS, Wilson PA, Wohl DA, Hightow-Weidman LB. Putting prevention in their pockets: developing mobile phone-based HIV interventions for black men who have sex with men. AIDS Patient Care STDS. 2013 Apr;27(4):211–22. doi: 10.1089/apc.2012.0404.
    1. Liu A, Coleman K, Bojan K, Serrano PA, Oyedele T, Garcia A, Enriquez-Bruce E, Emmanuel P, Jones J, Sullivan P, Hightow-Weidman L, Buchbinder S, Scott H. Developing a Mobile App (LYNX) to Support Linkage to HIV/Sexually Transmitted Infection Testing and Pre-Exposure Prophylaxis for Young Men Who Have Sex With Men: Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2019 Jan 25;8(1):e10659. doi: 10.2196/10659. v8i1e10659
    1. Fuchs JD, Stojanovski K, Vittinghoff E, McMahan VM, Hosek SG, Amico KR, Kouyate A, Gilmore HJ, Buchbinder SP, Lester RT, Grant RM, Liu AY. A Mobile Health Strategy to Support Adherence to Antiretroviral Preexposure Prophylaxis. AIDS Patient Care STDS. 2018 Mar;32(3):104–111. doi: 10.1089/apc.2017.0255.
    1. MacDonell KK, Naar S, Gibson-Scipio W, Lam P, Secord E. Multi-step development of a technology-based asthma adherence intervention for African American emerging adults. 121st American Psychological Association Convention; Jul 31-Aug 4, 2013; Honolulu, HA. 2013.
    1. Richard L, Gauvin L, Raine K. Ecological models revisited: their uses and evolution in health promotion over two decades. Annu Rev Public Health. 2011;32:307–26. doi: 10.1146/annurev-publhealth-031210-101141.
    1. Naar-King S, Montepiedra G, Garvie P, Kammerer B, Malee K, Sirois PA, Aaron L, Nichols SL, PACTG P1042s Team Social ecological predictors of longitudinal HIV treatment adherence in youth with perinatally acquired HIV. J Pediatr Psychol. 2013 Jul;38(6):664–74. doi: 10.1093/jpepsy/jst017. jst017
    1. Pinto RM, Berringer KR, Melendez R, Mmeje O. Improving PrEP Implementation Through Multilevel Interventions: A Synthesis of the Literature. AIDS Behav. 2018 Nov;22(11):3681–3691. doi: 10.1007/s10461-018-2184-4. 10.1007/s10461-018-2184-4
    1. Dubov A, Altice FL, Fraenkel L. An Information-Motivation-Behavioral Skills Model of PrEP Uptake. AIDS Behav. 2018 Nov;22(11):3603–3616. doi: 10.1007/s10461-018-2095-4.10.1007/s10461-018-2095-4
    1. Walsh JL. Applying the Information-Motivation-Behavioral Skills Model to Understand PrEP Intentions and Use Among Men Who Have Sex with Men. AIDS Behav. 2019 Jul;23(7):1904–1916. doi: 10.1007/s10461-018-2371-3. 10.1007/s10461-018-2371-3
    1. Miller W, Rollnick S. Motivational interviewing: Helping people change. New York, NY: Guilford Press; 2013.
    1. Coleman MT, Newton KS. Supporting self-management in patients with chronic illness. Am Fam Physician. 2005 Oct 15;72(8):1503–10.
    1. Wingood G, DiClemente R. The ADAPT-ITT model: a novel method of adapting evidence-based HIV Interventions. J Acquir Immune Defic Syndr. 2008 Mar 01;47 Suppl 1:S40–6. doi: 10.1097/QAI.0b013e3181605df1.00126334-200803011-00008
    1. Collins LM, Baker TB, Mermelstein RJ, Piper ME, Jorenby DE, Smith SS, Christiansen BA, Schlam TR, Cook JW, Fiore MC. The multiphase optimization strategy for engineering effective tobacco use interventions. Ann Behav Med. 2011 Apr;41(2):208–26. doi: 10.1007/s12160-010-9253-x.
    1. Collins LM, Dziak JJ, Kugler KC, Trail JB. Factorial experiments: efficient tools for evaluation of intervention components. Am J Prev Med. 2014 Oct;47(4):498–504. doi: 10.1016/j.amepre.2014.06.021. S0749-3797(14)00325-0
    1. Pellegrini CA, Hoffman SA, Collins LM, Spring B. Corrigendum to "Optimization of remotely delivered intensive lifestyle treatment for obesity using the Multiphase Optimization Strategy: Opt-IN study protocol" [Contemp. Clin. Trials 38 (2014) 251-259] Contemp Clin Trials. 2015 Nov;45(Pt B):468–469. doi: 10.1016/j.cct.2015.09.001. S1551-7144(15)00115-9
    1. Newman S, Andrews J, Magwood G, Jenkins C, Cox M, Williamson D. Community advisory boards in community-based participatory research: a synthesis of best processes. Prev Chronic Dis. 2011 May;8(3):A70. A70
    1. Dziak JJ, Nahum-Shani I, Collins LM. Multilevel factorial experiments for developing behavioral interventions: power, sample size, and resource considerations. Psychol Methods. 2012 Jun;17(2):153–75. doi: 10.1037/a0026972. 2012-02919-001
    1. US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States - 2017 Update: a clinical practice guideline. Centers for Disease Control and Prevention. 2018. [2022-03-15]. .
    1. Thai National Guidelines on Pre-Exposure Prophylaxis. Thailand Department of Disease Control. 2018. [2022-03-15]. .
    1. Phanuphak N, Jantarapakde J, Himmad L, Sungsing T, Meksena R, Phomthong S, Phoseeta P, Tongmuang S, Mingkwanrungruang P, Meekrua D, Sukthongsa S, Hongwiangchan S, Upanun N, Jirajariyavej S, Jadwattanakul T, Barisri S, Pankam T, Phanuphak P. Linkages to HIV confirmatory testing and antiretroviral therapy after online, supervised, HIV self-testing among Thai men who have sex with men and transgender women. J Int AIDS Soc. 2020 Jan;23(1):e25448. doi: 10.1002/jia2.25448.
    1. Phanuphak N, Anand T, Jantarapakde J, Nitpolprasert C, Himmad K, Sungsing T, Trachunthong D, Phomthong S, Phoseeta P, Tongmuang S, Mingkwanrungruang P, Meekrua D, Sukthongsa S, Hongwiangchan S, Upanun N, Barisri J, Pankam T, Phanuphak P. What would you choose: Online or Offline or Mixed services? Feasibility of online HIV counselling and testing among Thai men who have sex with men and transgender women and factors associated with service uptake. J Int AIDS Soc. 2018 Jul;21 Suppl 5:e25118. doi: 10.1002/jia2.25118.
    1. Des Jarlais DC, Paone D, Milliken J, Turner CF, Miller H, Gribble J, Shi Q, Hagan H, Friedman SR. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial. The Lancet. 1999 May;353(9165):1657–1661. doi: 10.1016/s0140-6736(98)07026-3.
    1. Kurth A, Martin D, Golden M, Weiss Noel S, Heagerty Patrick J, Spielberg Freya, Handsfield H Hunter, Holmes King K. A comparison between audio computer-assisted self-interviews and clinician interviews for obtaining the sexual history. Sex Transm Dis. 2004 Dec;31(12):719–26. doi: 10.1097/01.olq.0000145855.36181.13.00007435-200412000-00005
    1. Metzger DS, Koblin B, Turner C, Navaline H, Valenti F, Holte S, Gross M, Sheon A, Miller H, Cooley P, Seage G R. Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. Am J Epidemiol. 2000 Jul 15;152(2):99–106. doi: 10.1093/aje/152.2.99.
    1. Romer D, Hornik R, Stanton B, Black M, Li X, Ricardo I, Feigelman S. “Talking” computers: A reliable and private method to conduct interviews on sensitive topics with children. J Sex Res. 1997 Jan;34(1):3–9. doi: 10.1080/00224499709551859.
    1. Lapham SC, Henley E, Kleyboecker K. Prenatal behavioral risk screening by computer among Native Americans. Fam Med. 1993 Mar;25(3):197–202.
    1. Brooke J. SUS: A 'Quick and Dirty' Usability Scale. In: Jordan P, Thomas B, Weerdmeester B, McClelland I, editors. Usability Evaluation in Industry. London, UK: Taylor and Francis; 1996. pp. 189–194.
    1. Bangor A, Kortum P, Miller J. Determining what individual SUS scores mean: Adding an adjective rating scale. J Usability Stud. 2009;4(3):114–123.
    1. Kalichman SC, Amaral CM, Swetzes C, Jones M, Macy R, Kalichman MO, Cherry C. A simple single-item rating scale to measure medication adherence: further evidence for convergent validity. J Int Assoc Physicians AIDS Care (Chic) 2009;8(6):367–74. doi: 10.1177/1545109709352884. 8/6/367
    1. Blumenthal J, Pasipanodya EC, Jain S, Sun S, Ellorin E, Morris S, Moore DJ. Comparing Self-Report Pre-Exposure Prophylaxis Adherence Questions to Pharmacologic Measures of Recent and Cumulative Pre-Exposure Prophylaxis Exposure. Front Pharmacol. 2019;10:721. doi: 10.3389/fphar.2019.00721. doi: 10.3389/fphar.2019.00721.
    1. Collins LM, Kugler KC, Gwadz MV. Optimization of Multicomponent Behavioral and Biobehavioral Interventions for the Prevention and Treatment of HIV/AIDS. AIDS Behav. 2016 Jan;20 Suppl 1:S197–214. doi: 10.1007/s10461-015-1145-4. 10.1007/s10461-015-1145-4
    1. Landes SJ, McBain SA, Curran GM. Reprint of: An introduction to effectiveness-implementation hybrid designs. Psychiatry Res. 2020 Jan;283:112630. doi: 10.1016/j.psychres.2019.112630. S0165-1781(19)32168-7
    1. Final Recommendation Statement, Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis. US Preventive Services Task Force. [2020-10-12]. .

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj